Johnson & Johnson (NY:JNJ)

Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results

December 10, 2024

Empower 2024 Delivers Groundbreaking Insights and Innovation to Achieve Data-Driven Healthcare

November 04, 2024

Inovalon Unveils New Research, Products, and Solutions to Tackle Healthcare’s Most Complex Challenges

From Inovalon Holdings, Inc.

Via GlobeNewswire

Johnson & Johnson Stock: Setting the Stage for 2025 Highs

October 16, 2024

Healthcare giant and Dividend Aristocrat Johnson & Johnson is on track to hit new highs in 2025 and may sustain its rally well into 2026.

Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2024

October 15, 2024

Johnson & Johnson Reports Q3 2024 Results

October 15, 2024

Big pharmaceutical firms may lack the potential for rally driven by a breakout drug like small biotechs, but stability and steady growth remain attractive.

Best Pharma Stocks for Long-Term Investors: Growth and Dividends

October 14, 2024

Eli Lilly is the most valuable pharmaceutical company in the world. I believe the company has what it takes to stay there.

Why Eli Lilly Stock Is Soaring—and How It Plans to Stay on Top

October 13, 2024

Johnson & Johnson to Participate in the Stifel 2024 Healthcare Conference

October 10, 2024

Johnson & Johnson Completes Acquisition of V-Wave

October 09, 2024

Risk-averse investors can build a stable portfolio by focusing on established companies with consistent dividends and proven track records of success.

Top 3 Risk-Averse Stocks to Add Stability to Your Portfolio

October 07, 2024

These quality dividend stocks look significantly undervalued which gives you an opportunity to pair a high-yield dividend with strong capital appreciation

3 Undervalued Dividend Stocks Primed for Growth in 2025

October 07, 2024

Johnson & Johnson to Participate in the Guggenheim Global Healthcare Conference

October 04, 2024

Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer’s and More

October 03, 2024

Via Investor Brand Network

Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer’s and More

October 03, 2024

EQNX::TICKER_START (NYSE:ANVS),(NYSE:JNJ),(NYSE:NVS),(NYSE:MRK),(NYSE:GSK) EQNX::TICKER_END

Via FinancialNewsMedia

Attorneys Vow to Oppose J&J’s Third Bankruptcy Attempt

September 20, 2024

From Beasley Allen Law Firm

Johnson & Johnson Announces that its Subsidiary, Red River Talc LLC, has Filed a Voluntary Prepackaged Chapter 11 Case to Resolve All Current and Future Ovarian Cancer Talc Claims

September 20, 2024

These reliable dividend stocks are great buys, with shares still near the bottom of long-term ranges and accelerating growth expected in 2025.

Top 3 Dividend Stocks to Beat Market Volatility and Boost Returns

September 17, 2024

Secure your portfolio with stocks known for their stability and reliable dividend payouts, offering a sense of security during uncertain times.

Topics Economy

3 Safe Stocks with Safe Dividends for Your Portfolio

September 11, 2024

Topics Economy

Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results

September 05, 2024

Johnson & Johnson’s Executive Vice President, Chief Human Resources Officer Peter Fasolo to Retire; Kristen Mulholland Named Chief Human Resources Officer, Effective October 1, 2024

August 26, 2024

Shield your investments from market volatility with these four resilient defensive stocks, offering stability and potential growth despite uncertainty.

4 Defensive Stocks to Combat Market Fear, Uncertainty, and Doubt

August 20, 2024

Topics Economy

Johnson & Johnson to Acquire V-Wave

August 20, 2024

These three stocks have a long history of increasing their dividends and are likely to benefit from sector rotation on expectations of lower interest rates

Lock in Gains: 3 Dividend Stocks Poised to Boost Payouts Soon

August 16, 2024

BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Reports on ‘Synergistic Effect’ of Lead Compound Plus GLP-1 in AD Treatment Model

Topics Artificial Intelligence Economy

August 08, 2024

Via Investor Brand Network

Alzheimer’s Disease Diagnostics & Therapeutics Market Driven by Use of Biomarkers and Advancing R&D Activities

August 06, 2024

EQNX::TICKER_START (NYSE:ANVS),(NYSE:MRK),(NASDAQ:SNY),(NYSE:JNJ),(NYSE:NVS) EQNX::TICKER_END

Via FinancialNewsMedia

Alzheimer's Disease Diagnostics & Therapeutics Market Driven by Use of Biomarkers and Advancing R&D Activities

August 06, 2024

From FN Media Group LLC

Via GlobeNewswire

3 Defensive Stocks Weathering the Market Storm

August 05, 2024

Despite last week's market downturn, JNJ, KO, and PG posted gains, demonstrating resilience and potentially serving as defensive safe-haven investments.

The healthcare sector, represented by the XLV ETF, has seen a resurgence, breaking out of a multi-year consolidation phase and surging almost 3% in July.

Topics Economy Stocks

Top 2 Cheap Healthcare Stocks to Buy as Sector Outperforms

July 30, 2024

Topics ETFs

Johnson & Johnson to Participate in the 2024 Wells Fargo Healthcare Conference

July 29, 2024